The Landscape of Patient Access to Direct Acting Antivirals by Payer Within the United States Healthcare System

The Landscape of Patient Access to Direct Acting Antivirals by Payer Within the United States... Curr Hepatology Rep (2017) 16:192–197 DOI 10.1007/s11901-017-0359-5 HEPATITIS C (J AHN AND A ARONSOHN, SECTION EDITORS) The Landscape of Patient Access to Direct Acting Antivirals by Payer Within the United States Healthcare System 1 2 3 Leah DB Carter & Mai T. Pho & Andrew Aronsohn Published online: 19 July 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review This review article charts the current land- scape of patient access to direct acting antivirals (DAAs) by As the leading cause of liver transplant and liver-related death payer within the United States healthcare system, including in the USA, hepatitis C (HCV) affects nearly 3.5 million Medicaid, Medicare, private/commercial health insurance, Americans and exceeds HIV and AIDS in number of deaths Department of Corrections, and the Department of Veteran’s globally. HCV elimination has been declared a health priority Affairs. Each payer is reviewed for barriers to access and by the World Health Organization (WHO), the United equity as well as analyzed with regard to cost. Nations, World Health Assembly, and the National Academy Recent Findings The advent of DAAs gives the promise not of Sciences [1, 2�� ]. Toward the aim of elimination, WHO just of cure but of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Hepatology Reports Springer Journals

The Landscape of Patient Access to Direct Acting Antivirals by Payer Within the United States Healthcare System

Loading next page...
 
/lp/springer_journal/the-landscape-of-patient-access-to-direct-acting-antivirals-by-payer-Gv2E6AIDoV
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Hepatology
eISSN
2195-9595
D.O.I.
10.1007/s11901-017-0359-5
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial